24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cancer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:04
"Cyber solutions will have to be reinvented to remain relevant for AI"
12:16
Advanced Israeli weaponry playing major role in Azerbaijan’s Nagorno-Karabakh offensive
10:46
Snyk losses surged to $267 million in 2022 despite 157% increase in revenue
10:21
Is the Samsung Galaxy Z Fold 5 worth the investment? A detailed analysis
More stories
Buzz
Most popular
Daily
Weekly
1
Black Cube Moves into Larger, Fancier Headquarters
2
Is the iPhone 15 Pro worth the upgrade? In-depth review and analysis
3
Palo Alto Networks in advanced negotiations to acquire Dig Security in $300-$400 million deal
4
Investments in Israeli startups fall for a seventh straight quarter
5
Blockchain unicorn Fireblocks acquires Australian tokenization startup BlockFold
More news
Cancer
20 stories about Cancer
Ibex Medical raises $55 million Series C for AI-powered cancer diagnostics
06.09.23
|
Meir Orbach
The Israeli startup’s platform provides health systems and diagnostic laboratories with an integrated solution for cancer diagnosis and biomarker scoring, capable of detecting more than 100 different cancer and non-cancer pathologies
Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors
30.11.22
|
Meir Orbach
The Israeli company is aiming to achieve new standards for efficacy and patient response across a number of difficult-to-treat cancers
Is it time to reconsider PSA tests for Prostate Cancer?
01.09.22
|
Itay Barnea
“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect
Collaboration is the key to advancing cancer care
30.08.22
|
Ofer Sharon
Israel can become a precision oncology powerhouse, but we need to change direction, writes Dr. Ofer Sharon, CEO of OncoHost
SpotitEarly raises $6.2 million for early detection of cancers based on olfactory abilities of dogs
23.06.22
|
CTech
Each type of cancer has a unique odor, and most also have a common denominator. Dogs can detect these odors in a fraction of a second
Larry Ellison leads $21.5 million Series A in cancer treatment startup Imagene AI
02.05.22
|
Meir Orbach
Using only a digitized biopsy image, the Israeli startup’s diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes
“I still feel like Cinderella and that I’m here by mistake”
16.04.22
|
Diana Bahur-Nir
After beating multiple cancers, former Chief Scientist Orna Berry turned being a cancer survivor into a hobby
Nucleix announces $22 million in funding, advancements in lung cancer detection program
05.01.22
|
Meir Orbach
The Israeli company develops non-invasive, DNA methylation-based cancer screening tests for early-stage and recurring cancer detection
Israeli companies send nanotechnology cancer treatment experiment to space aboard SpaceX
26.12.21
|
CTech
The drug, developed in Israel by Ayana Pharma, will be tested under zero-gravity conditions after being launched last week in a smart laboratory belonging to Israeli company SpacePharma aboard Elon Musk's Falcon 9 launcher
KAHR announced $46.5 million funding round to advance its immunotherapeutic pipeline
16.06.21
|
James Spiro
The round will be used to advance the clinical development of KAHR’s lead product candidate, DSP107
Ibex Medical Analytics granted ‘Breakthrough Device Designation’ by the FDA, fast-tracking its approval
09.06.21
|
James Spiro
The U.S Food and Drug Administration formally acknowledged its Galen platform and the potential benefit it has on American patients
Ibex obtains CE Mark for AI-powered breast cancer detection
26.05.21
|
James Spiro
The Ibex Galen Breast solution can detect multiple types of breast cancer and provide accurate diagnoses
Israel’s IceCure granted FDA Breakthrough Medical Device designation
04.04.21
|
Hezi Sternlicht
The decision puts the company’s tumor-freezing technology on the fast track for final approval
Ibex Medical Analytics raises $38 million for AI-powered cancer diagnostics solutions
09.03.21
|
Meir Orbach
Ibex’s solutions detect cancer in real-time, enabling 100% quality control, while also reducing turnaround times
Israel’s aMoon fund saw a 15-fold return on its investment in Seer
09.12.20
|
Sophie Shulman
aMoon invested in the U.S. biomed company when it was valued at $228 million- after a Nasdaq IPO, its value ballooned to $3.5 billion
Limaca Medical raises $1.25 million for precision biopsy device
11.11.20
|
Yafit Ovadia
The medical device company’s solution refines ultrasound-guided biopsies to improve tumor detection and other cancer diagnoses
Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold
12.10.20
|
Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
Israel’s Ibex Medical Analytics Deploys in Puerto Rico, establishing a foothold in the Americas
01.09.20
|
James Spiro
Its Galen Prostate solution helps pathologists with more accurate diagnoses and improves lab efficiency
The cure is out there: Miniature space labs are leading to scientific breakthroughs
08.08.20
|
Yoghev Carmel
From attempts to crack the aging process to developing asthma medicine, the most innovative medical experiments are taking place these days in space
Israeli healthtech VC aMoon Velocity invests $6 million in Nectin Therapeutics
15.07.20
|
James Spiro
Nectin Therapeutics places antibodies in proteins known to cause cancer, improving immune systems and blocking certain checkpoints
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility